SIMILAR PATTERNS OF AMINO ACIDS FOR 2CML_B_ZMRB2478_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1a0j TRYPSIN

(Salmo salar) 		PF00089
(Trypsin) 		4 SER A 145
SER A 147
SER A 148
ASN A 150
 None
 1.07A 2cmlB-1a0jA:
undetectable		 2cmlB-1a0jA:
21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1aye PROCARBOXYPEPTIDASE
A2

(Homo sapiens) 		PF00246
(Peptidase_M14)
PF02244
(Propep_M14) 		4 SER A 162
ASP A 163
SER A 164
SER A 157
 None
 1.01A 2cmlB-1ayeA:
undetectable		 2cmlB-1ayeA:
23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dtd CARBOXYPEPTIDASE A2

(Homo sapiens) 		PF00246
(Peptidase_M14) 		4 ASP A 519
SER A 520
SER A 513
ASN A 515
 None
 1.12A 2cmlB-1dtdA:
undetectable		 2cmlB-1dtdA:
22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dzt DTDP-4-DEHYDRORHAMNO
SE 3,5-EPIMERASE

(Salmonella
enterica) 		PF00908
(dTDP_sugar_isom) 		4 SER A 140
SER A 142
SER A 143
ASN A  69
 None
 1.09A 2cmlB-1dztA:
undetectable		 2cmlB-1dztA:
18.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fs2 SKP2

(Homo sapiens) 		PF12937
(F-box-like) 		4 SER A 276
SER A 250
ASN A 248
GLN A 196
 None
 1.13A 2cmlB-1fs2A:
undetectable		 2cmlB-1fs2A:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fs2 SKP2

(Homo sapiens) 		PF12937
(F-box-like) 		4 SER A 303
ASP A 331
SER A 276
ASN A 301
 None
 1.06A 2cmlB-1fs2A:
undetectable		 2cmlB-1fs2A:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jl5 OUTER PROTEIN YOPM

(Yersinia pestis) 		PF12468
(TTSSLRR) 		4 SER A1305
SER A1306
SER A1285
ASN A1303
 None
 1.04A 2cmlB-1jl5A:
undetectable		 2cmlB-1jl5A:
20.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1nmb N9 NEURAMINIDASE

(Influenza A
virus) 		PF00064
(Neur) 		4 SER N 367
SER N 370
SER N 372
TRP N 403
 None
 0.69A 2cmlB-1nmbN:
70.5		 2cmlB-1nmbN:
68.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1nmb N9 NEURAMINIDASE

(Influenza A
virus) 		PF00064
(Neur) 		4 SER N 367
SER N 370
TRP N 403
LYS N 432
 None
 0.59A 2cmlB-1nmbN:
70.5		 2cmlB-1nmbN:
68.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1v0z NEURAMINIDASE

(Influenza A
virus) 		PF00064
(Neur) 		8 SER A 374
ASP A 376
SER A 377
SER A 379
ASN A 406
GLN A 407
TRP A 409
LYS A 440
 None
 0.34A 2cmlB-1v0zA:
76.2		 2cmlB-1v0zA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1xog NEURAMINIDASE

(Influenza A
virus) 		PF00064
(Neur) 		6 SER A 368
SER A 371
SER A 373
ASN A 400
TRP A 403
LYS A 434
 None
 0.77A 2cmlB-1xogA:
71.5		 2cmlB-1xogA:
69.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ass S-PHASE
KINASE-ASSOCIATED
PROTEIN 2

(Homo sapiens) 		PF12937
(F-box-like) 		4 SER B2291
ASP B2319
SER B2264
ASN B2289
 None
 0.98A 2cmlB-2assB:
undetectable		 2cmlB-2assB:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2b0r POSSIBLE ADENYL
CYCLASE-ASSOCIATED
PROTEIN

(Cryptosporidium
parvum) 		PF08603
(CAP_C) 		4 SER A 111
SER A 112
SER A  93
ASN A  92
 None
 1.06A 2cmlB-2b0rA:
undetectable		 2cmlB-2b0rA:
22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2coe DEOXYNUCLEOTIDYLTRAN
SFERASE, TERMINAL
VARIANT

(Homo sapiens) 		PF00533
(BRCT) 		4 SER A  71
ASP A  72
SER A  69
SER A 115
 None
 1.10A 2cmlB-2coeA:
undetectable		 2cmlB-2coeA:
17.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2htv NEURAMINIDASE

(Influenza A
virus) 		PF00064
(Neur) 		5 SER A 367
SER A 370
SER A 372
ASN A 400
TRP A 403
 None
 0.44A 2cmlB-2htvA:
62.9		 2cmlB-2htvA:
45.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2htv NEURAMINIDASE

(Influenza A
virus) 		PF00064
(Neur) 		5 SER A 367
SER A 372
ASN A 400
TRP A 403
LYS A 432
 None
 0.69A 2cmlB-2htvA:
62.9		 2cmlB-2htvA:
45.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2m26 HCF C-TERMINAL CHAIN
1

(Mus musculus) 		no annotation 4 SER A  83
ASP A 122
SER A 123
SER A  79
 None
 1.01A 2cmlB-2m26A:
undetectable		 2cmlB-2m26A:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2mjm PROTEIN NLRC5

(Mus musculus) 		no annotation 4 SER A  10
ASP A   7
SER A  96
TRP A  98
 None
 1.14A 2cmlB-2mjmA:
undetectable		 2cmlB-2mjmA:
13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2no5 (S)-2-HALOACID
DEHALOGENASE IVA

(Burkholderia
cepacia) 		PF13419
(HAD_2) 		4 SER A 215
ASP A 100
SER A 217
ASN A 214
 SO4  A1006 ( 2.8A)
SO4  A1006 ( 3.7A)
SO4  A1006 ( 4.4A)
None
 1.02A 2cmlB-2no5A:
undetectable		 2cmlB-2no5A:
22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p5z TYPE VI SECRETION
SYSTEM COMPONENT

(Escherichia
coli) 		PF05954
(Phage_GPD) 		4 SER X  98
SER X  96
GLN X  46
LYS X  52
 None
 1.11A 2cmlB-2p5zX:
undetectable		 2cmlB-2p5zX:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2v7g UROCANATE HYDRATASE

(Pseudomonas
putida) 		PF01175
(Urocanase)
PF17391
(Urocanase_N)
PF17392
(Urocanase_C) 		5 SER A 237
ASP A 213
SER A 193
ASN A 195
GLN A 182
 None
 1.43A 2cmlB-2v7gA:
undetectable		 2cmlB-2v7gA:
20.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wy3 UNCHARACTERIZED
PROTEIN UL16

(Human
betaherpesvirus
5) 		PF17622
(UL16) 		4 SER B  33
SER B  34
SER B  31
GLN B  94
 None
NAG  B1202 (-2.8A)
None
None
 1.01A 2cmlB-2wy3B:
undetectable		 2cmlB-2wy3B:
17.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2x7j 2-SUCCINYL-5-ENOLPYR
UVYL-6-HYDROXY-3-CYC
LOHEXENE
-1-CARBOXYLATE
SYNTHASE

(Bacillus
subtilis) 		PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
PF16582
(TPP_enzyme_M_2) 		4 ASP A 252
SER A 255
ASN A 259
GLN A 418
 None
 1.06A 2cmlB-2x7jA:
undetectable		 2cmlB-2x7jA:
19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yeq ALKALINE PHOSPHATASE
D

(Bacillus
subtilis) 		PF09423
(PhoD)
PF16655
(PhoD_N) 		4 ASP A 350
SER A 351
ASN A 291
TRP A 337
 None
None
EDO  A 540 ( 4.3A)
None
 1.12A 2cmlB-2yeqA:
undetectable		 2cmlB-2yeqA:
20.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yjq CEL44C

(Paenibacillus
polymyxa) 		PF12891
(Glyco_hydro_44) 		4 SER A 455
ASP A 457
SER A 458
ASN A 432
 None
 0.76A 2cmlB-2yjqA:
undetectable		 2cmlB-2yjqA:
20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z7x TOLL-LIKE RECEPTOR
1, VARIABLE
LYMPHOCYTE RECEPTOR
B

(Eptatretus
burgeri;
Homo sapiens) 		PF11921
(DUF3439)
PF13855
(LRR_8) 		4 SER B 431
SER B 432
SER B 406
ASN B 429
 NAG  A 831 (-3.6A)
NAG  A 833 ( 3.9A)
NAG  A 831 (-3.0A)
NAG  A 831 (-1.8A)
 0.99A 2cmlB-2z7xB:
undetectable		 2cmlB-2z7xB:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z7x TOLL-LIKE RECEPTOR
2, VARIABLE
LYMPHOCYTE RECEPTOR
B

(Eptatretus
burgeri;
Homo sapiens) 		PF11921
(DUF3439)
PF13855
(LRR_8) 		4 SER A 444
SER A 445
SER A 421
ASN A 442
 NAG  A 921 ( 4.4A)
None
NAG  A 921 (-2.5A)
NAG  A 921 (-1.8A)
 0.86A 2cmlB-2z7xA:
undetectable		 2cmlB-2z7xA:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z81 TOLL-LIKE RECEPTOR
2, VARIABLE
LYMPHOCYTE RECEPTOR
B

(Eptatretus
burgeri;
Mus musculus) 		PF11921
(DUF3439)
PF13306
(LRR_5)
PF13516
(LRR_6)
PF13855
(LRR_8) 		4 SER A 444
SER A 445
SER A 421
ASN A 442
 NAG  A 811 ( 4.3A)
None
NAG  A 811 (-3.4A)
NAG  A 811 (-1.8A)
 0.91A 2cmlB-2z81A:
undetectable		 2cmlB-2z81A:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a79 TOLL-LIKE RECEPTOR
6, VARIABLE
LYMPHOCYTE RECEPTOR
B

(Eptatretus
burgeri;
Mus musculus) 		PF11921
(DUF3439)
PF13855
(LRR_8) 		4 SER B 436
SER B 437
SER B 411
ASN B 434
 NDG  B 971 (-3.6A)
NAG  B 972 ( 4.2A)
NDG  B 971 (-2.7A)
NDG  B 971 (-2.1A)
 0.94A 2cmlB-3a79B:
undetectable		 2cmlB-3a79B:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a8u OMEGA-AMINO
ACID--PYRUVATE
AMINOTRANSFERASE

(Pseudomonas
putida) 		PF00202
(Aminotran_3) 		4 ASP X 117
SER X 118
SER X 120
ASN X 156
 None
PLP  X 450 (-3.8A)
PLP  X 450 (-2.6A)
None
 1.00A 2cmlB-3a8uX:
undetectable		 2cmlB-3a8uX:
21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bzw PUTATIVE LIPASE

(Bacteroides
thetaiotaomicron) 		PF13472
(Lipase_GDSL_2) 		4 ASP A 203
SER A 191
ASN A 242
GLN A 248
 None
 0.99A 2cmlB-3bzwA:
undetectable		 2cmlB-3bzwA:
20.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ckz NEURAMINIDASE

(Influenza A
virus) 		PF00064
(Neur) 		4 SER A 367
SER A 370
TRP A 403
LYS A 432
 None
 0.72A 2cmlB-3ckzA:
64.2		 2cmlB-3ckzA:
47.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ckz NEURAMINIDASE

(Influenza A
virus) 		PF00064
(Neur) 		4 SER A 367
SER A 372
TRP A 403
LYS A 432
 None
 0.77A 2cmlB-3ckzA:
64.2		 2cmlB-3ckzA:
47.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ehm SUSD HOMOLOG

(Bacteroides
thetaiotaomicron) 		PF12741
(SusD-like) 		5 SER A 242
ASP A 239
SER A 241
ASN A 197
GLN A 196
 None
 1.50A 2cmlB-3ehmA:
undetectable		 2cmlB-3ehmA:
19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ico 6-PHOSPHOGLUCONOLACT
ONASE

(Mycobacterium
tuberculosis) 		PF01182
(Glucosamine_iso) 		4 SER A  11
ASP A  10
SER A 202
ASN A  45
 None
 1.14A 2cmlB-3icoA:
undetectable		 2cmlB-3icoA:
18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j70 ENVELOPE
GLYCOPROTEIN GP120

(Human
immunodeficiency
virus 1) 		PF00516
(GP120) 		4 SER D 405
ASN D 340
GLN D 344
TRP D 395
 None
 0.98A 2cmlB-3j70D:
undetectable		 2cmlB-3j70D:
20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ll3 GLUCONATE KINASE

(Lactobacillus
acidophilus) 		PF00370
(FGGY_N)
PF02782
(FGGY_C) 		4 SER A 241
ASP A 237
SER A 427
GLN A 425
 None
XUL  A7778 (-2.9A)
None
None
 1.01A 2cmlB-3ll3A:
undetectable		 2cmlB-3ll3A:
20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o53 PROTEIN LRIM1

(Anopheles
gambiae) 		PF00560
(LRR_1)
PF13855
(LRR_8) 		4 SER A  88
SER A  89
SER A  64
ASN A  86
 NAG  A1001 (-3.4A)
NAG  A1002 ( 4.9A)
NAG  A1001 (-3.6A)
NAG  A1001 (-1.7A)
 1.07A 2cmlB-3o53A:
undetectable		 2cmlB-3o53A:
21.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oja LEUCINE-RICH IMMUNE
MOLECULE 1

(Anopheles
gambiae) 		PF00560
(LRR_1) 		4 SER A  88
SER A  89
SER A  64
ASN A  86
 NAG  A1001 ( 4.4A)
None
NAG  A1001 (-3.1A)
NAG  A1001 (-1.8A)
 0.98A 2cmlB-3ojaA:
undetectable		 2cmlB-3ojaA:
19.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pvl MYOSIN VIIA ISOFORM
1

(Mus musculus) 		PF00784
(MyTH4) 		5 SER A1184
SER A1186
SER A1187
ASN A1182
GLN A1178
 None
 1.47A 2cmlB-3pvlA:
undetectable		 2cmlB-3pvlA:
20.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qum FAB 5D5A5 HEAVY
CHAIN
PROSTATE-SPECIFIC
ANTIGEN

(Homo sapiens;
Mus musculus) 		PF00089
(Trypsin)
PF07654
(C1-set)
PF07686
(V-set) 		4 SER B  30
SER B  53
SER P  86
GLN P  50
 None
 0.97A 2cmlB-3qumB:
undetectable		 2cmlB-3qumB:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r3j GLUTAMATE
DEHYDROGENASE

(Plasmodium
falciparum) 		PF00208
(ELFV_dehydrog)
PF02812
(ELFV_dehydrog_N) 		4 SER A 479
ASP A 487
SER A 486
GLN A 474
 None
 1.09A 2cmlB-3r3jA:
undetectable		 2cmlB-3r3jA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sqg METHYL-COENZYME M
REDUCTASE, BETA
SUBUNIT

(uncultured
archaeon) 		PF02241
(MCR_beta)
PF02783
(MCR_beta_N) 		4 SER B 356
SER B 355
SER B 359
GLN B 321
 None
 1.02A 2cmlB-3sqgB:
undetectable		 2cmlB-3sqgB:
21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t1e HEMAGGLUTININ-NEURAM
INIDASE

(Avian
avulavirus 1) 		PF00423
(HN) 		4 SER A 517
SER A 518
SER A 519
ASN A 549
 None
 1.08A 2cmlB-3t1eA:
21.7		 2cmlB-3t1eA:
21.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ti8 NEURAMINIDASE

(Influenza A
virus) 		PF00064
(Neur) 		5 SER A 367
SER A 370
SER A 372
ASN A 400
TRP A 403
 None
 0.52A 2cmlB-3ti8A:
64.8		 2cmlB-3ti8A:
45.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3tia NEURAMINIDASE

(Influenza A
virus) 		PF00064
(Neur) 		5 SER A 367
SER A 370
SER A 372
ASN A 400
TRP A 403
 None
 0.46A 2cmlB-3tiaA:
64.8		 2cmlB-3tiaA:
43.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3whs GAMMA-GLUTAMYLTRANSP
EPTIDASE SMALL CHAIN

(Bacillus
subtilis) 		PF01019
(G_glu_transpept) 		4 SER B 520
SER B 522
SER B 523
ASN B 519
 None
 0.97A 2cmlB-3whsB:
undetectable		 2cmlB-3whsB:
20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wpe TOLL-LIKE RECEPTOR 9

(Bos taurus) 		PF13516
(LRR_6)
PF13855
(LRR_8) 		4 SER A 148
SER A 150
SER A 130
ASN A 128
 None
 0.84A 2cmlB-3wpeA:
undetectable		 2cmlB-3wpeA:
19.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aez WD REPEAT-CONTAINING
PROTEIN SLP1

(Schizosaccharomyces
pombe) 		PF00400
(WD40)
PF12894
(ANAPC4_WD40) 		4 ASP A 208
SER A 209
SER A 211
GLN A 253
 None
 1.08A 2cmlB-4aezA:
6.4		 2cmlB-4aezA:
21.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4b7j NEURAMINIDASE

(Influenza A
virus) 		PF00064
(Neur) 		4 SER A 364
SER A 366
SER A 367
ASN A 369
 None
 1.11A 2cmlB-4b7jA:
64.1		 2cmlB-4b7jA:
38.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bjj TRANSCRIPTION FACTOR
TAU SUBUNIT SFC1

(Schizosaccharomyces
pombe) 		PF09734
(Tau95) 		4 SER A   7
ASP A   8
SER A  91
ASN A  89
 None
 0.91A 2cmlB-4bjjA:
undetectable		 2cmlB-4bjjA:
13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bx9 VACUOLAR PROTEIN
SORTING-ASSOCIATED
PROTEIN 33A

(Homo sapiens) 		PF00995
(Sec1) 		4 ASP A 372
ASN A 390
GLN A 413
LYS A 405
 None
 1.10A 2cmlB-4bx9A:
undetectable		 2cmlB-4bx9A:
21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gji L-RHAMNOSE ISOMERASE

(Pseudomonas
stutzeri) 		no annotation 4 ASP A 124
SER A  99
GLN A 328
TRP A  57
 None
None
None
RNS  A1001 (-3.5A)
 0.80A 2cmlB-4gjiA:
undetectable		 2cmlB-4gjiA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gos V-SET
DOMAIN-CONTAINING
T-CELL ACTIVATION
INHIBITOR 1

(Homo sapiens) 		PF07686
(V-set) 		4 SER A  55
SER A 114
ASN A 112
GLN A 107
 NAG  A 202 ( 4.5A)
NAG  A 201 (-3.2A)
NAG  A 201 (-1.9A)
NAG  A 201 (-4.7A)
 1.10A 2cmlB-4gosA:
undetectable		 2cmlB-4gosA:
15.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gvr METHENYLTETRAHYDROME
THANOPTERIN
CYCLOHYDROLASE

(Archaeoglobus
fulgidus) 		PF02289
(MCH) 		4 ASP A 227
SER A 228
SER A 181
GLN A 179
 None
 1.06A 2cmlB-4gvrA:
undetectable		 2cmlB-4gvrA:
21.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4h53 NEURAMINIDASE

(Influenza A
virus) 		PF00064
(Neur) 		5 SER A 367
SER A 370
SER A 372
ASN A 400
TRP A 403
 SIA  A 510 (-2.5A)
SIA  A 510 (-2.6A)
SIA  A 510 (-2.8A)
SIA  A 510 (-3.4A)
SIA  A 510 (-3.5A)
 0.48A 2cmlB-4h53A:
64.7		 2cmlB-4h53A:
51.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hcr PF-547659 HEAVY
CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		4 SER H 104
ASP H 106
SER H 102
SER H 103
 None
 1.12A 2cmlB-4hcrH:
undetectable		 2cmlB-4hcrH:
19.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hzz NEURAMINIDASE

(Influenza A
virus) 		PF00064
(Neur) 		4 SER A 367
SER A 372
ASN A 400
TRP A 403
 None
 0.30A 2cmlB-4hzzA:
62.8		 2cmlB-4hzzA:
50.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4io1 RIBOSE-5-PHOSPHATE
ISOMERASE A

(Francisella
tularensis) 		PF06026
(Rib_5-P_isom_A) 		4 SER A  59
ASP A  61
SER A  62
SER A  58
 None
 1.05A 2cmlB-4io1A:
undetectable		 2cmlB-4io1A:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iug BETA-GALACTOSIDASE A

(Aspergillus
oryzae) 		PF01301
(Glyco_hydro_35)
PF10435
(BetaGal_dom2)
PF13363
(BetaGal_dom3)
PF13364
(BetaGal_dom4_5) 		4 SER A 464
SER A 442
SER A 440
ASN A 466
 None
 0.97A 2cmlB-4iugA:
undetectable		 2cmlB-4iugA:
17.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4izx RICIN B-LIKE LECTIN

(Macrolepiota
procera) 		PF14200
(RicinB_lectin_2) 		4 SER A  60
SER A  62
SER A  57
TRP A  44
 None
 0.88A 2cmlB-4izxA:
undetectable		 2cmlB-4izxA:
16.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4j0m SERINE/THREONINE-PRO
TEIN KINASE
BRI1-LIKE 1

(Arabidopsis
thaliana) 		PF08263
(LRRNT_2)
PF13516
(LRR_6)
PF13855
(LRR_8) 		5 ASP A 207
SER A 183
SER A 159
ASN A 157
GLN A 110
 None
None
NAG  A 811 (-3.5A)
NAG  A 811 (-1.8A)
None
 1.29A 2cmlB-4j0mA:
undetectable		 2cmlB-4j0mA:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kfz ANTI-LMO2 VH

(Homo sapiens) 		PF07686
(V-set) 		4 SER C  56
SER C  57
SER C  52
ASN C  54
 None
 1.07A 2cmlB-4kfzC:
undetectable		 2cmlB-4kfzC:
16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m69 MIXED LINEAGE KINASE
DOMAIN-LIKE PROTEIN

(Mus musculus) 		PF07714
(Pkinase_Tyr) 		4 SER B 320
SER B 322
SER B 323
ASN B 318
 None
 1.11A 2cmlB-4m69B:
undetectable		 2cmlB-4m69B:
21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m7e PROTEIN
BRASSINOSTEROID
INSENSITIVE 1

(Arabidopsis
thaliana) 		PF00560
(LRR_1)
PF08263
(LRRNT_2)
PF12799
(LRR_4)
PF13516
(LRR_6)
PF13855
(LRR_8) 		4 SER A 277
SER A 278
SER A 253
ASN A 275
 NAG  A 803 (-3.1A)
NAG  A 804 ( 4.1A)
NAG  A 803 (-2.3A)
NAG  A 803 (-1.7A)
 0.96A 2cmlB-4m7eA:
undetectable		 2cmlB-4m7eA:
19.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4mju NEURAMINIDASE

(Influenza A
virus) 		PF00064
(Neur) 		5 SER A 367
SER A 370
SER A 372
ASN A 400
TRP A 403
 None
 0.37A 2cmlB-4mjuA:
62.8		 2cmlB-4mjuA:
48.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nzu 13PL LIGHT CHAIN

(Homo sapiens) 		PF07654
(C1-set)
PF07686
(V-set) 		4 SER H  55
SER H  56
SER H  52
ASN H  53
 None
 1.00A 2cmlB-4nzuH:
undetectable		 2cmlB-4nzuH:
20.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4qn3 NEURAMINIDASE

(Influenza A
virus) 		PF00064
(Neur) 		5 SER A 286
SER A 289
SER A 291
ASN A 318
TRP A 321
 None
 0.40A 2cmlB-4qn3A:
72.3		 2cmlB-4qn3A:
61.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r40 PROTEIN TOLB

(Yersinia pestis) 		PF04052
(TolB_N)
PF07676
(PD40) 		4 SER A 288
SER A 306
ASN A 269
GLN A 282
 FMT  A 502 (-3.3A)
None
None
None
 1.08A 2cmlB-4r40A:
7.1		 2cmlB-4r40A:
23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r4z PNGF-II

(Elizabethkingia
meningoseptica) 		PF09112
(N-glycanase_N)
PF09113
(N-glycanase_C) 		4 SER A 471
SER A 481
SER A 479
ASN A 473
 None
 1.06A 2cmlB-4r4zA:
undetectable		 2cmlB-4r4zA:
19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r6f LEUCINE RICH REPEAT
DLRR_I

(synthetic
construct) 		PF12354
(Internalin_N)
PF13855
(LRR_8) 		4 SER A 196
SER A 197
SER A 164
ASN A 194
 None
 0.99A 2cmlB-4r6fA:
undetectable		 2cmlB-4r6fA:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r6f LEUCINE RICH REPEAT
DLRR_I

(synthetic
construct) 		PF12354
(Internalin_N)
PF13855
(LRR_8) 		4 SER A 276
SER A 277
SER A 244
ASN A 274
 None
 1.03A 2cmlB-4r6fA:
undetectable		 2cmlB-4r6fA:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rcj YTH
DOMAIN-CONTAINING
FAMILY PROTEIN 1

(Homo sapiens) 		PF04146
(YTH) 		4 SER A 398
ASP A 400
SER A 396
TRP A 411
 None
 1.12A 2cmlB-4rcjA:
undetectable		 2cmlB-4rcjA:
19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uii GGDEF DOMAIN PROTEIN

(Azotobacter
vinelandii) 		PF11563
(Protoglobin) 		4 ASP A  83
SER A  81
SER A  79
GLN A  72
 None
 1.07A 2cmlB-4uiiA:
undetectable		 2cmlB-4uiiA:
17.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uwa RYANODINE RECEPTOR 1

(Oryctolagus
cuniculus) 		PF00622
(SPRY)
PF01365
(RYDR_ITPR)
PF02026
(RyR)
PF02815
(MIR)
PF08709
(Ins145_P3_rec) 		4 SER A1171
ASP A1172
SER A1173
SER A1175
 None
 1.00A 2cmlB-4uwaA:
undetectable		 2cmlB-4uwaA:
7.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4v1y ATRAZINE
CHLOROHYDROLASE

(Pseudomonas sp.
ADP) 		PF01979
(Amidohydro_1) 		4 SER A 301
ASP A 327
SER A 331
GLN A  83
 None
FE  A 481 (-2.8A)
None
None
 1.03A 2cmlB-4v1yA:
undetectable		 2cmlB-4v1yA:
19.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y4v CONSERVED
HYPOTHETICAL
SECRETED PROTEIN

(Helicobacter
pylori) 		PF03734
(YkuD) 		4 SER A 274
ASP A 294
SER A 273
ASN A  66
 None
 1.02A 2cmlB-4y4vA:
undetectable		 2cmlB-4y4vA:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yhc STEROL REGULATORY
ELEMENT-BINDING
PROTEIN
CLEAVAGE-ACTIVATING
PROTEIN

(Schizosaccharomyces
pombe) 		no annotation 4 SER A 838
SER A 850
SER A 851
GLN A1003
 None
 1.05A 2cmlB-4yhcA:
5.3		 2cmlB-4yhcA:
20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z6g MICROTUBULE-ACTIN
CROSS-LINKING FACTOR
1, ISOFORMS 1/2/3/5

(Homo sapiens) 		PF00307
(CH) 		4 SER A 187
SER A 247
SER A 188
ASN A 185
 None
 1.14A 2cmlB-4z6gA:
undetectable		 2cmlB-4z6gA:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5c2k TRANSFORMING PROTEIN
RHOA,RAC
GTPASE-ACTIVATING
PROTEIN 1

(Homo sapiens) 		PF00071
(Ras)
PF00620
(RhoGAP) 		4 SER A  88
ASP A  90
SER A  91
SER A  85
 None
 1.12A 2cmlB-5c2kA:
undetectable		 2cmlB-5c2kA:
19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5diz PROTEINACEOUS RNASE
P 2

(Arabidopsis
thaliana) 		PF16953
(PRORP)
PF17177
(PPR_long) 		4 SER A 114
SER A 111
ASN A 108
GLN A  66
 None
 1.02A 2cmlB-5dizA:
undetectable		 2cmlB-5dizA:
22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e0q ANTI-NUP98 NANOBODY
TP377
NUCLEAR PORE COMPLEX
PROTEIN NUP98-NUP96

(Vicugna pacos;
Xenopus
tropicalis) 		PF04096
(Nucleoporin2)
PF07686
(V-set) 		4 ASP B 775
SER B 776
SER A  57
ASN A  54
 None
 0.90A 2cmlB-5e0qB:
undetectable		 2cmlB-5e0qB:
18.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ejy MYOSIN-I HEAVY CHAIN

(Dictyostelium
discoideum) 		PF00784
(MyTH4) 		4 SER A 276
SER A 263
SER A 267
ASN A 279
 None
 1.07A 2cmlB-5ejyA:
undetectable		 2cmlB-5ejyA:
19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fp2 FERRIC ENTEROBACTIN
RECEPTOR PIRA

(Pseudomonas
aeruginosa) 		PF00593
(TonB_dep_Rec)
PF07715
(Plug) 		4 ASP A 615
SER A 582
SER A 584
GLN A  33
 None
 0.98A 2cmlB-5fp2A:
undetectable		 2cmlB-5fp2A:
20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gqr LEUCINE-RICH REPEAT
RECEPTOR-LIKE
PROTEIN KINASE TDR

(Arabidopsis
thaliana) 		PF00560
(LRR_1)
PF08263
(LRRNT_2)
PF13855
(LRR_8) 		4 SER B 495
SER B 497
SER B 473
ASN B 471
 None
 0.91A 2cmlB-5gqrB:
undetectable		 2cmlB-5gqrB:
20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hdh TOLL-LIKE RECEPTOR 8

(Homo sapiens) 		PF13855
(LRR_8) 		4 SER A  71
ASP A  72
SER A  50
ASN A  93
 None
 1.05A 2cmlB-5hdhA:
undetectable		 2cmlB-5hdhA:
17.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5k59 UNCHARACTERIZED
LEUKOCIDIN-LIKE
PROTEIN 2

(Staphylococcus
aureus) 		no annotation 4 ASP D 152
SER D 144
SER D 164
ASN D 163
 None
 1.13A 2cmlB-5k59D:
undetectable		 2cmlB-5k59D:
19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mqm GLYCOSYL HYDROLASES
FAMILY 2, SUGAR
BINDING DOMAIN

(Bacteroides
thetaiotaomicron) 		PF17132
(Glyco_hydro_106) 		4 SER A 580
ASP A 758
SER A 759
SER A 696
 None
 1.03A 2cmlB-5mqmA:
undetectable		 2cmlB-5mqmA:
15.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5oc1 ARYL-ALCOHOL OXIDASE

(Pleurotus
eryngii) 		no annotation 4 SER A 210
ASP A  38
SER A 209
ASN A  15
 None
 1.05A 2cmlB-5oc1A:
undetectable		 2cmlB-5oc1A:
20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5te1 ATP-CITRATE SYNTHASE

(Homo sapiens) 		PF00549
(Ligase_CoA)
PF02629
(CoA_binding)
PF16114
(Citrate_bind) 		4 SER A 574
SER A 577
GLN A 505
TRP A 502
 None
 1.03A 2cmlB-5te1A:
undetectable		 2cmlB-5te1A:
19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tet ATP-CITRATE SYNTHASE

(Homo sapiens) 		PF00549
(Ligase_CoA)
PF02629
(CoA_binding) 		4 SER B 574
SER B 577
GLN B 505
TRP B 502
 None
 1.03A 2cmlB-5tetB:
undetectable		 2cmlB-5tetB:
22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5v13 AAEL008620-PA
ODORANT-BINDING
PROTEIN

(Aedes aegypti) 		no annotation 4 SER B  40
GLN B  62
TRP B  50
LYS B  47
 None
 1.13A 2cmlB-5v13B:
undetectable		 2cmlB-5v13B:
22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wve APOPTOTIC
PROTEASE-ACTIVATING
FACTOR 1

(Homo sapiens) 		PF00400
(WD40)
PF00931
(NB-ARC) 		4 SER A 891
ASP A 893
SER A 895
SER A 896
 None
 1.04A 2cmlB-5wveA:
3.0		 2cmlB-5wveA:
13.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x4j UNCHARACTERIZED
PROTEIN

(Pyrococcus
furiosus) 		no annotation 4 SER A 135
ASP A  36
SER A 137
ASN A 177
 None
ZN  A 501 (-3.1A)
None
None
 1.11A 2cmlB-5x4jA:
undetectable		 2cmlB-5x4jA:
11.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xnu PUTATIVE INTEGRAL
MEMBRANE PROTEIN

(Escherichia
coli) 		no annotation 4 SER A 274
ASP A 507
SER A 506
ASN A 254
 None
 1.01A 2cmlB-5xnuA:
undetectable		 2cmlB-5xnuA:
11.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5zln TOLL-LIKE RECEPTOR 9

(Mus musculus) 		no annotation 4 SER A 149
SER A 151
SER A 131
ASN A 129
 None
 0.88A 2cmlB-5zlnA:
undetectable		 2cmlB-5zlnA:
14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5zln TOLL-LIKE RECEPTOR 9

(Mus musculus) 		no annotation 5 SER A 503
ASP A 528
SER A 505
SER A 481
GLN A 399
 None
 1.40A 2cmlB-5zlnA:
undetectable		 2cmlB-5zlnA:
14.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6byw GOXA

(Pseudoalteromonas
luteoviolacea) 		no annotation 4 SER B 308
SER B 310
SER B 311
ASN B 321
 None
 0.80A 2cmlB-6bywB:
undetectable		 2cmlB-6bywB:
10.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cc2 CELL DIVISION
CONTROL PROTEIN 45
CDC45 PUTATIVE

(Entamoeba
histolytica) 		no annotation 4 SER A 516
ASP A 518
SER A 519
ASN A  59
 None
 1.14A 2cmlB-6cc2A:
undetectable		 2cmlB-6cc2A:
12.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fi2 VEXL

(Achromobacter
denitrificans) 		no annotation 4 SER A 313
SER A 259
SER A 257
GLN A 231
 None
None
None
DJB  A 503 ( 3.3A)
 1.07A 2cmlB-6fi2A:
undetectable		 2cmlB-6fi2A:
12.24